Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors

Cancer

Volumn 79, Issue 4, 1997, Pages 830-834

  Trendle, Michael C ^a   Moertel, Charles G ^a   Kvols, Larry K ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

cholecystitis; cholelithiasis; islet cell tumors; metastatic carcinoid; octreotide

Indexed keywords

OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ACUTE CHOLECYSTITIS; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CARCINOID; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; GALLSTONE FORMATION; HUMAN; INCIDENCE; MALE; MORBIDITY; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031057466     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19970215)79:4<830::aid-cncr20>3.0.co;2-%23     Document Type: Article

References (33)

1. Liuzzi A, Sobrinho LG, Besser GM. Practical approaches to the diagnosis and treatment of acromegaly. Metabolism 1992; 41(9 Suppl 2):87-90.
2. Ho KY, Weissberger AJ, Marbach P, Lazarus L. Therapeutic efficacy of the somatostatin analogue SMS 201-995 (octreotide) in acromegaly. Ann Intern Med 1990; 112:173-81.
3. Hajarizadeh H, Ivancev K, Mueller CR, Fletcher WS, Woltering EA. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg 1992; 163:479-83.
4. Creutzfeldt W, Bartsch HH, Jacubaschke U, Stockmann F. Treatment of gastrointestinal endocrine tumors with interferon-alpha and octreotide. Acta Oncol 1991; 30:529-35.
5. Kvols LK, Buck M, Moertel CG, Schutt AJ, Rubin J, O'Connell MJ, et al. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 1987; 107:162-8.
6. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991;325:1461-7.
7. Cello JP, Grendell JH, Basuk D, Simon D, Weiss L, Wittner M, et al. Effect of octreotide on refractory AIDS-associated diarrhea. Ann Intern Med 1991;115:705-10.
8. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986;315:663-6.
9. Woods HF, Bax ND, Ainsworth I. Abdominal carcinoid tumors in Sheffield. Digestion 1990; 45(Suppl 1):17-22.
10. Ganda OP, Weir GC, Soeldner JS. Somatostatinoma: a somatostatin containing tumor of the endocrine pancreas. N Engl J Med 1977;296:963-7.
11. Larsson LI, Hirsch MA, Holst JJ, Ingemansson S, Kuhl C, Kensen SL, et al. Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet 1977; 1(8013):666-8.
12. Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, et al. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 1979;301:285-92.
13. Wass JA, Popovic V, Chayvialle JA. Tolerability and safety of Sandostatin. Metabolism 1992;41(9 Suppl 2):80-2.
14. Sassolas G. The role of Sandostatin in acromegaly. Metabolism 1992; 41(9 Suppl 2):39-43.
15. Wass JA, Anderson JV, Besser GM, Dowling RH. Gallstones and treatment with octreotide for acromegaly. BMJ 1989; 299:1162-3.
16. Eastman RC, Arakaki RF, Shawker T, Schock R, Roach P, Gordon P, et al. A prospective examination of octreotide-induced gallbladder changes in acromegaly. Clin Endocrinol (Oxf) 1992;36:265-9.
17. Roti E, Minelli R, Gardini E, Salvi M, Bianconi L, Balducci L et al. Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis. J Endocrinol Invest 1990; 13:69-72.
18. Christensen SE, Weeke J, Orskov H, Kaal A, Lund E, Jorgensen J, et al. Long-term efficacy and tolerability of octreotide treatment in acromegaly. Metabolism 1992;41(9 Suppl 2): 44-50.
19. Plockinger U, Dienemann D, Quabbe HJ. Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. J Clin Endocrinol Metab 1990;71:1658-62.
20. Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function, and hormone release in normal men. Digestion 1987;36:108-24.
21. Creutzfeldt W, Lembcke B, Folsch UR, Schleser S, Koop I. Effect of somatostain analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med 1987; 2(5B):49-54.
22. Hussaini SH, Murphy GM, Kennedy C, Wass JAH, Dowling RH. Chronic octreotide treatment of acromegaly induces changes in gallbladder bile composition which predispose to gallstones. Gastroenterology 1993; 104(4 P 2):A365.
23. Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JAH. Gallstones during octreotide therapy. Metabolism 1992;41(9 Suppl 2):22-33.
24. Buscail J, Tauber JP, Puel-Basquet C. Gallstones and treatment with octreotide for acromegaly. BMJ 1989;299:1162.
25. Ewins DL, Javaid A, Coskeran PB, Shah S, Butler J, Deprez PH, et al. Assessment of gallbladder dynsmics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med 1992;83:295-306.
26. Stolk MF, van Erpecum KJ, de Bruin WI, Koppeschaar H, Jansen JMBJ, Lamers CBHW, et al. Gallbladder motility and CCK release during intermittent and continuous administration of SMS 201-995 in acromegalics. J Hepatol 1991; 13:S73.
27. Rhodes M, James RA, Bird M, Clayton B, Kendall-Taylor P, Lennard TWl. Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment. Scand J Gastroenterol 1992; 27:115-8.
28. Lee SP, Carey MC, LaMont JT. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981; 211:1429-31.
29. Zakko S. Diagnostic imaging before and after dissolution of gallbladder stones. Recenti Prog Med 1992;83:407-15.
30. Marzio L, Innocenti P, Genovesi N, Di Felice F, Napolitano AM, Contantini R, et al. Role of oral cholecystography, realtime ultrasound, and CT in evaluation of gallstones and gallbladder function. Gastrointestinal Radiology 1992; 17:257-61.
31. Page MD, Millward ME, Taylor A, Preece M, Hourihan M, Hall R, et al. Long-term treatment of acromegaly with a longacting analogue of somatostatin, octreotide. Q J Med 1990; 74:189-201.
32. Tauber JP, Babin TL, Tauber MT, Vigoni F, Bonafe A, Ducasse M, et al. Long-term effects of continuous subcutaneous infusion of the somatostatin analogue octreotide in the treatment of acromegaly. J Clin Endocrinol Metab 1989; 68:917-24.
33. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108:1091-6.